Current MRR
$2,090.97
Verified monthly run-rate
GlowAgain
GlowAgain is built for people using GLP-1 medications like Mounjaro®, Zepbound®, Ozempic®, Wegovy®, and compounded semaglutide or tirzepatide. It helps you track your progress, manage your shots, and feel in control again — all in one place.
Revenue (30d)
$1,164.85
Verified in the last 30 days
All-time revenue
$1,507.05
Verified lifetime total
Category rank
#13
See who ranks above · Health & Fitness
Global rank
#338
See the global chart
Verified MRR history
First weekThe revenue career
Sep 3$2,090.97 current
Acquisition paybackOpen TrustMRR Listing
Payback for GlowAgain
Estimate months to break even from verified monthly revenue, your assumed net margin, and optional growth.
Estimated payback
5.0 yr
Rough break-even around Sep 2031 (flat run-rate).
- Est. monthly profit
- $836.39
- Revenue multiple
- 2.0x
- Profit multiple
- 5.0x
- Annualized profit
- $10,036.66
Disclaimer: This calculator is for educational underwriting only and is not investment, financial, or legal advice. Margin and growth are your assumptions; always verify figures on the listing before you buy.
Category ladder
Full category chartHealth & Fitness chart
Podium leaders plus who sits near GlowAgain. Ranked by verified 30-day revenue.
Similar Startup Explorer
Startups like GlowAgain
Browse peers by MRR or 30d revenue, growth, market, tech stack, pricing, or customer count. Check up to 2 to compare side by side.
Select up to 2 peers to compare with GlowAgain
Select peers firstThis week's story
GlowAgain just landed on ChartMRR at $2,090.97 MRR. The first weekly move unlocks after the next snapshot.